Align Technology Net Income/Loss 2012-2026 | ALGN
Align Technology annual/quarterly net income/loss history and growth rate from 2012 to 2026. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
- Align Technology net income/loss for the quarter ending March 31, 2026 was $0.275B, a 13.53% decline year-over-year.
- Align Technology net income/loss for the twelve months ending March 31, 2026 was $1.007B, a 5.82% decline year-over-year.
- Align Technology annual net income/loss for 2024 was $0.421B, a 5.32% decline from 2023.
- Align Technology annual net income/loss for 2023 was $0.445B, a 23.09% increase from 2022.
- Align Technology annual net income/loss for 2022 was $0.362B, a 53.17% decline from 2021.
|
Align Technology Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $421 |
| 2023 | $445 |
| 2022 | $362 |
| 2021 | $772 |
| 2020 | $1,776 |
| 2019 | $443 |
| 2018 | $400 |
| 2017 | $231 |
| 2016 | $190 |
| 2015 | $144 |
| 2014 | $146 |
| 2013 | $64 |
| 2012 | $59 |
| 2011 | $67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $12.400B | $4.035B |
| Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |